Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
The price of Immunic Inc (NASDAQ: IMUX) closed at $1.01 in the last session, down -0.98% from day before closing price of $1.02. In other words, the price has decreased by -$0.98 from its previous closing price. On the day, 0.8 million shares were traded.
Ratios:
We take a closer look at IMUX’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 1.77 and its Current Ratio is at 1.77. In the meantime, Its Debt-to-Equity ratio is 0.05 whereas as Long-Term Debt/Eq ratio is at 0.01.
On November 25, 2024, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $10.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Nov 12 ’24 when Rudick Richard Alan bought 87,300 shares for $1.15 per share. The transaction valued at 100,369 led to the insider holds 87,300 shares of the business.
Stock Price History:
Over the past 52 weeks, IMUX has reached a high of $2.11, while it has fallen to a 52-week low of $0.83. The 50-Day Moving Average of the stock is -7.05%, while the 200-Day Moving Average is calculated to be -17.37%.
Shares Statistics:
A total of 95.82M shares are outstanding, with a floating share count of 92.92M. Insiders hold about 3.02% of the company’s shares, while institutions hold 51.82% stake in the company.
